Suppr超能文献

miRNAs 在韩国骨髓增生异常综合征患者中的表达及预后意义。

Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.

机构信息

Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

Korean J Intern Med. 2019 Mar;34(2):390-400. doi: 10.3904/kjim.2016.239. Epub 2017 Nov 15.

Abstract

BACKGROUND/AIMS: Various alterations of microRNA (miRNA) expression have been reported in myelodysplastic syndrome (MDS). We aimed to investigate the unique patterns and prognostic significance of miRNA expression in Korean patients with MDS.

METHODS

Bone marrow mononuclear cells were collected from eight healthy controls and 26 patients with MDS, and miRNAs were isolated and assessed via quantitative real-time polymerase chain reaction for selected miRNAs, including miR-21, miR-124a, miR-126, miR-146b-5p, miR-155, miR-182, miR-200c, miR-342-5p, miR-708, and Let-7a.

RESULTS

MiR-124a, miR-155, miR-182, miR-200c, miR-342-5p, and Let-7a were significantly underexpressed in patients with MDS, compared to healthy controls. MiR-21, miR-126, 146b-5p, and miR-155 transcript levels were significantly lower in international prognostic scoring system lower (low and intermediate-1) risk MDS than in higher (intermediate-2 and high) risk MDS. Higher expression levels of miR-126 and miR-155 correlated with significantly shorter overall survival and leukemia-free survival. Higher miR-124a expression also tended to be related to shorter survivals.

CONCLUSION

Although our study was limited by the relatively small number of patients included, we identified several miRNAs associated with pathogenesis, leukemic transformation, and prognosis in MDS.

摘要

背景/目的:多种 miRNA(miRNA)表达改变已在骨髓增生异常综合征(MDS)中报道。我们旨在研究 miRNA 表达在韩国 MDS 患者中的独特模式和预后意义。

方法

从 8 名健康对照者和 26 名 MDS 患者的骨髓单核细胞中收集骨髓单核细胞,并通过定量实时聚合酶链反应(qRT-PCR)评估选定 miRNA(包括 miR-21、miR-124a、miR-126、miR-146b-5p、miR-155、miR-182、miR-200c、miR-342-5p、miR-708 和 Let-7a)的 miRNA 表达。

结果

与健康对照者相比,MDS 患者 miR-124a、miR-155、miR-182、miR-200c、miR-342-5p 和 Let-7a 表达显著下调。国际预后评分系统低(低和中-1)风险 MDS 患者 miR-21、miR-126、146b-5p 和 miR-155 转录水平显著低于高(中-2 和高)风险 MDS 患者。miR-126 和 miR-155 的高表达水平与总生存和无白血病生存显著缩短相关。miR-124a 表达较高也与生存时间缩短相关。

结论

尽管我们的研究受到纳入患者数量相对较少的限制,但我们确定了一些与 MDS 发病机制、白血病转化和预后相关的 miRNA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd1/6406090/416224c30cf8/kjim-2016-239f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验